Anatole Cessot

940 total citations
30 papers, 562 citations indexed

About

Anatole Cessot is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Anatole Cessot has authored 30 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Anatole Cessot's work include Colorectal Cancer Treatments and Studies (8 papers), Cancer Treatment and Pharmacology (6 papers) and Renal cell carcinoma treatment (4 papers). Anatole Cessot is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Cancer Treatment and Pharmacology (6 papers) and Renal cell carcinoma treatment (4 papers). Anatole Cessot collaborates with scholars based in France, United States and Guadeloupe. Anatole Cessot's co-authors include Romain Coriat, Jean-Philippe Durand, François Goldwasser, Olivier Mir, Pascaline Boudou‐Rouquette, Olivier Huillard, Benoı̂t Blanchet, Michel Vidal, Audrey Thomas‐Schoemann and François Goldwasser and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Anatole Cessot

27 papers receiving 549 citations

Peers

Anatole Cessot

ONCOL

PRM

HEMAT

J. Alexandre France

Yasuhito Fujisaka Japan

Nazan Günel Türkiye

Felipe Melo Cruz Brazil

Muhammad Salim United States

A. Preston United States

Amy Drobish United States

Kristin Kaley United States

Nancy Harold United States

Suzanne M. Fields United States

J. Alexandre France

Anatole Cessot

370 ×1.1

ONCOL

205 ×1.1

PRM

170 ×1.2

61 ×0.8

55 ×0.8

HEMAT

Citations per year, relative to Anatole Cessot Anatole Cessot (= 1×) peers J. Alexandre

Countries citing papers authored by Anatole Cessot

Since Specialization

Citations

This map shows the geographic impact of Anatole Cessot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anatole Cessot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anatole Cessot more than expected).

Fields of papers citing papers by Anatole Cessot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anatole Cessot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anatole Cessot. The network helps show where Anatole Cessot may publish in the future.

Co-authorship network of co-authors of Anatole Cessot

This figure shows the co-authorship network connecting the top 25 collaborators of Anatole Cessot. A scholar is included among the top collaborators of Anatole Cessot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anatole Cessot. Anatole Cessot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hélissey, Carole, Anatole Cessot, Laurys Boudin, et al.. (2021). How did we take care of our older cancer patients during the first COVID-19 wave? The French experience. Bulletin du Cancer. 108(6). 589–595. 1 indexed citations

Hélissey, Carole, Anatole Cessot, Laurys Boudin, et al.. (2020). Evaluation of medical practices in oncology in the context of the COVID‐19 pandemic in France: Physicians’ point of view: the PRATICOVID study. Cancer Medicine. 9(23). 8875–8883. 6 indexed citations

Hélissey, Carole, Anatole Cessot, Laurys Boudin, et al.. (2020). 1728P Evaluation of medical practices in oncology in a context of COVID-19 pandemic in France: Point of view of physicians, PRATICOVID study. Annals of Oncology. 31. S1013–S1013. 1 indexed citations

Cabel, Luc, Benoı̂t Blanchet, Audrey Thomas‐Schoemann, et al.. (2017). Drug monitoring of sunitinib in patients with advanced solid tumors: a monocentric observational French study. Fundamental and Clinical Pharmacology. 32(1). 98–107. 24 indexed citations

Bretagne, Marie, Pascaline Boudou‐Rouquette, Olivier Huillard, et al.. (2016). Inhibiteurs de tyrosine kinase ciblant l’angiogenèse et sujets âgés : tolérance, évaluation pré-thérapeutique et gestion des effets indésirables. Bulletin du Cancer. 103(3). 259–272. 4 indexed citations

Noé, Gaëlle, Olivier Huillard, Lisa Golmard, et al.. (2016). Relation between plasma trough concentration of abiraterone and prostate-specific antigen response in metastatic castration-resistant prostate cancer patients. European Journal of Cancer. 72. 54–61. 49 indexed citations

Beinse, Guillaume, George Emile, Anatole Cessot, et al.. (2016). A Real-Life Experience of Bevacizumab in Elderly Women With Advanced Ovarian Carcinoma. International Journal of Gynecological Cancer. 26(7). 1196–1200. 7 indexed citations

Bigot, Frédéric, Pascaline Boudou‐Rouquette, Jennifer Arrondeau, et al.. (2016). Erlotinib pharmacokinetics: a critical parameter influencing acute toxicity in elderly patients over 75 years-old. Investigational New Drugs. 35(2). 242–246. 20 indexed citations

Arrondeau, Jennifer, Olivier Huillard, Camille Tlemsani, et al.. (2015). Investigational therapies up to Phase II which target PDGF receptors: potential anti-cancer therapeutics. Expert Opinion on Investigational Drugs. 24(5). 673–687. 7 indexed citations

10.

Chapuis, Nicolas, George Emile, Anatole Cessot, et al.. (2015). Risk factors for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia over time: assessment of monocyte count and baseline clinical parameters. Cancer Chemotherapy and Pharmacology. 76(5). 1033–1039. 8 indexed citations

11.

Tlemsani, Camille, Olivier Huillard, Jennifer Arrondeau, et al.. (2015). Effect of glucuronidation on transport and tissue accumulation of tyrosine kinase inhibitors: consequences for the clinical management of sorafenib and regorafenib. Expert Opinion on Drug Metabolism & Toxicology. 11(5). 785–794. 32 indexed citations

12.

Cessot, Anatole, Romain Coriat, Olivier Mir, et al.. (2013). Nutritional Status Is Superior to the ECOG Performance Status in Predicting the Dose-Intensity of the GEMOX Chemotherapy Regimen in Patients with Advanced Cancer. Nutrition and Cancer. 65(8). 1254–1257. 5 indexed citations

13.

Giroux, Julie, Marie Briet, Pascaline Boudou‐Rouquette, et al.. (2013). Arterial stiffness to predict hypertensive response to antiangiogenic drugs.. Journal of Clinical Oncology. 31(15_suppl). e13589–e13589. 1 indexed citations

14.

Pallier, Karine, Anatole Cessot, Jean‐François Côté, et al.. (2012). TWIST1 a New Determinant of Epithelial to Mesenchymal Transition in EGFR Mutated Lung Adenocarcinoma. PLoS ONE. 7(1). e29954–e29954. 51 indexed citations

15.

Mir, Olivier, Romain Coriat, Pascaline Boudou‐Rouquette, et al.. (2012). Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib. Medical Oncology. 29(4). 2793–2799. 34 indexed citations

16.

Mir, Olivier, Jean-Philippe Durand, Pascaline Boudou‐Rouquette, et al.. (2012). Interaction between serotonin reuptake inhibitors, 5-HT3 antagonists, and NK1 antagonists in cancer patients receiving highly emetogenic chemotherapy: a case–control study. Supportive Care in Cancer. 20(9). 2235–2239. 8 indexed citations

17.

Durand, Jean-Philippe, et al.. (2011). Validation of the Cochin Risk Index Score (CRIS) for life expectancy prediction in terminally ill cancer patients. Supportive Care in Cancer. 20(4). 857–864. 13 indexed citations

18.

Durand, Jean-Philippe, G. Deplanque, J.M. Gornet, et al.. (2011). Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial. Annals of Oncology. 23(1). 200–205. 144 indexed citations

19.

Just, Pierre‐Alexandre, Aurélie Cazes, Anne Audebourg, et al.. (2011). Histologic subtypes, immunohistochemistry, FISH or molecular screening for the accurate diagnosis of ALK-rearrangement in lung cancer: A comprehensive study of Caucasian non-smokers. Lung Cancer. 76(3). 309–315. 49 indexed citations

20.

Coriat, Romain, Olivier Mir, Anatole Cessot, et al.. (2010). Feasibility of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) in cirrhotic or liver transplant patients: experience in a cohort of advanced hepatocellular carcinoma patients. Investigational New Drugs. 30(1). 376–381. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact